Teicoplanin and vancomycin as treatment for glycopeptide-susceptible Enterococcus faecium bacteraemia: a propensity score-adjusted non-inferior comparative study.
Ryo YamaguchiTakehito YamamotoKoh OkamotoSohei HaradaMiho EchizenyaTakeya TsutsumiTappei TakadaPublished in: The Journal of antimicrobial chemotherapy (2023)
Teicoplanin is a safe and useful alternative therapeutic agent for treating GSEF bacteraemia.